Background Angiotensin converting-enzyme (ACE) inhibitors used for the treatment of heart
failure relieve symptoms, increase exercise performance, reduce hospital admissions and …

OBJECTIVES We sought to prospectively and randomly compare survival with clinical and
hemodynamic variables in patients with congestive heart failure (CHF) treated with standard …

Multiclinic controlled studies have shown that enalapril alone 10 to 40 mg/day orally is
effective in lowering blood pressure in patients with essential hypertension. Enalapril has …

Although a cornerstone in the treatment of heart failure, angiotensin-converting enzyme
inhibitors are under-used, partly due to side effects. If proven at least similarly efficacious to …

Background—Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …

Background Angiotensin-converting enzyme (ACE) inhibitors are established as first-line
therapy in chronic heart failure (CHF). However, conflicting results exist regarding the dose …

BACKGROUND: Whether an angiotensin receptor blocker is of benefit when added to a full
dose of angiotensin-converting enzyme (ACE) inhibitor in heart failure (HF) is uncertain …

Aims To investigate the effect of valsartan in the Valsartan‐Heart Failure Trial (Val‐HeFT)
when added to angiotensin‐converting enzyme inhibitor (ACEi) alone in patients with heart …

The effectiveness of the different angiotensin-converting enzyme (ACE) inhibitors in the
treatment of patients with congestive heart failure (CHF) was compared by performing a …

ACE inhibitors have significantly decreased cardiovascular mortality, myocardial infarction
(MI), and hospitalizations for heart failure (HF) in patients with asymptomatic or symptomatic …